Article info
PDFClinical and epidemiological research
Extended report
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity
- Correspondence to Dr Iago Pinal-Fernandez or Dr Andrew L Mammen, Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1141, Building 50, MSC 8024, Bethesda, MD 20892, USA; iagopf{at}yahoo.es and andrew.mammen{at}nih.gov.
Citation
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity
Publication history
- Received July 11, 2016
- Revised August 12, 2016
- Accepted August 27, 2016
- First published September 20, 2016.
Online issue publication
March 10, 2017
Article Versions
- Previous version (20 September 2016).
- Previous version (3 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/